A small study in ALS and Guillain-Barré syndrome with anti-NTD and anti-CTD antibodies showed increased TDP-43 levels in the CSF of ALS patients [62], reinforcing the relationship between TDP-43 levels in CSF and TDP-43 proteinopathy. Here, TARDBP is linked to Guillain-Barre syndrome.